Lung mass appearing as a dilated left ventricle on Tc-99m tetrofosmin myocardial perfusion scintigraphy.
暂无分享,去创建一个
[1] J. Fitting,et al. [Current approach to bronchial carcinoid tumors]. , 2007, Revue medicale suisse.
[2] O. Schillaci,et al. Mediastinal lymph node involvement in non-small cell lung cancer: evaluation with 99mTc-tetrofosmin SPECT and comparison with CT. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[3] O. Schillaci,et al. The usefulness of 99mTc-tetrofosmin SPECT in the detection of intrathoracic malignant lesions. , 2003, International Journal of Oncology.
[4] H. Schicha,et al. Use of myocardial imaging agents for tumour diagnosis – a success story? , 2000, European Journal of Nuclear Medicine.
[5] J R Galvin,et al. Thoracic carcinoids: radiologic-pathologic correlation. , 1999, Radiographics : a review publication of the Radiological Society of North America, Inc.
[6] T. Araki,et al. Uptake of technetium-99m-tetrofosmin, technetium-99m-MIBI and thallium-201 in tumor cell lines. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[7] M. Moore,et al. Technetium-99m-tetrofosmin as a substrate for P-glycoprotein: in vitro studies in multidrug-resistant breast tumor cells. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[8] F. Smith,et al. Technetium-99m-1,2-bis[bis(2-ethoxyethyl) phosphino]ethane: human biodistribution, dosimetry and safety of a new myocardial perfusion imaging agent. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.